Lijnen P, Amery A, Fagard R, Verschueren L
J Endocrinol. 1980 Apr;85(1):137-43. doi: 10.1677/joe.0.0850137.
The biological significance of active and inactive renin was investigated by comparison of an in-vitro assay of active, total and inactive plasma renin concentration (PRC), plasma renin activity (PRA) and plasma concentrations of angiotensin I and II with an in-vivo change in mean arterial blood pressure (MAP) produced by antagonism of angiotensin with treatment with saralasin and by blockade of angiotensin-converting enzyme by treatment with captopril. A significant relationship between the changes in MAP during treatment with saralasin and captopril with the pretreatment levels of PRA, active and total PRC and angiotensin II were found; while the pre-existing level of inactive renin was not a predictor for the hypotensive effect of saralasin and captopril. During treatment with saralasin and captopril significant increases in PRA, plasma angiotensin I concentration and total and active PRC were found and no change in inactive PRC was observed.
通过比较活性、总血浆肾素浓度(PRC)、无活性血浆肾素浓度、血浆肾素活性(PRA)以及血管紧张素I和II的血浆浓度的体外测定结果,与用沙拉新拮抗血管紧张素以及用卡托普利阻断血管紧张素转换酶治疗后平均动脉血压(MAP)的体内变化,研究了活性和无活性肾素的生物学意义。发现用沙拉新和卡托普利治疗期间MAP的变化与PRA、活性和总PRC以及血管紧张素II的预处理水平之间存在显著关系;而预先存在的无活性肾素水平并不是沙拉新和卡托普利降压效果的预测指标。在用沙拉新和卡托普利治疗期间,发现PRA、血浆血管紧张素I浓度以及总PRC和活性PRC显著增加,而无活性PRC未观察到变化。